Neomycin Sulfate CAS#1405-10-3

  • Broad-Spectrum Antibacterial Activity – Effective against both gram-positive and gram-negative bacteria, making it versatile for treating bacterial infections.
  • Multiple Mechanisms of Action – Inhibits bacterial protein synthesis by binding to prokaryotic ribosomes and also modulates cellular enzymes such as PLC, PLD, and PLA2.
  • Protects DNA Integrity – Inhibits DNase I–induced DNA degradation, supporting cellular protection in research and medical applications.
  • Topical Therapeutic Use – Commonly used to prevent or treat bacterial skin infections, offering a reliable option for dermatological applications.

Product Details

Neomycin sulfate is an aminoglycoside antibiotic and a calcium channel protein inhibitor. It binds to prokaryotic ribosomes, inhibiting protein translation, and is effective against both gram-positive and gram-negative bacteria. Additionally, it inhibits PLC (Phospholipase C) by binding to inositol phospholipids, suppresses phosphatidylcholine-PLD activity, and induces Ca²⁺ mobilization and PLA2 activation in human platelets. Neomycin sulfate also prevents DNase I–induced DNA degradation. It is primarily used to prevent or treat bacterial skin infections and is not effective against fungal or viral infections.

Neomycin Sulfate CAS#1405-10-3

Neomycin sulfate Chemical Properties

Melting point >187°C (dec.)
Alpha D20 +54° (c = 2 in H2O)
Bulk density640kg/m3
Refractive index 56 ° (C=10, H2O)
Fp 56℃
Storage temp2-8°C
Solubility H2O: 50 mg/mL As a stock solution. Stock solutions should be filter sterilized and stored at 2-8°C. Stable at 37°C for 5 days.
Form powder
Color white to slightly yellow
PH5.0-7.5 (50g/l, H2O, 20℃)
Biological sourceStreptomyces sp
Water Solubility Soluble in water
Merck 14,6454
StabilityStable. Incompatible with strong oxidizing agents.
InChIKeyOIXVKQDWLFHVGR-VTSVPHRWSA-N
LogP-3.655 (est)
CAS DataBase Reference1405-10-3(CAS DataBase Reference)
EPA Substance Registry SystemNeomycin sulfate (1405-10-3)

Safety Information

Hazard Codes Xn,Xi
Risk Statements 42/43-22
Safety Statements 23-36/37-45-22-36-24/25
WGK Germany 3
RTECS QP4375000
8
TSCA Yes
HS Code 29419000
ToxicityLD50 oral in mouse: > 8gm

Neomycin sulfate is an aminoglycoside antibiotic produced by S. fradiae that inhibits protein translation by binding to the small subunit of prokaryotic ribosomes. It blocks voltage-sensitive Ca²⁺ channels and acts as a potent inhibitor of Ca²⁺ release from skeletal muscle sarcoplasmic reticulum. Neomycin sulfate has been shown to inhibit inositol phospholipid turnover, phospholipase C, and phosphatidylcholine–phospholipase D activity (IC50 = 65 μM). It is highly effective against both Gram-positive and Gram-negative bacteria and is commonly used to prevent bacterial contamination in cell cultures.

Online Consultation

Please fill out the form below and we will contact you as soon as possible